Articles for author: Russ Cohen

Russ Cohen

Most Popular

Allarity Therapeutics, Inc. Securities Fraud Lawsuit: An Investor’s Opportunity Allarity Therapeutics, Inc. Securities Fraud Lawsuit: An Investor’s Opportunity

LOS ANGELES, Oct. 3, 2024 — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have an opportunity to lead the securities fraud class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) ALLR. Class Period: May 17, 2022 – July 19, 2024 Lead Plaintiff Deadline: November 12, 2024 If you ...

Russ Cohen

Most Popular

Top Defensive Stocks Garnering High-Dividend Yields Insight into High-Dividend Yield Defensive Stocks

In tumultuous market conditions, investors often seek refuge in dividend-yielding stocks. These companies, with robust free cash flows, generously reward shareholders with substantial dividend payouts. For astute investors, navigating the stock market is crucial. Delving into analyst ratings provides key insights, especially when mulling over high-yielding stocks in the consumer staples sector. Walgreens Boots Alliance, ...

Russ Cohen

Most Popular

Unveiling Twilio’s Avant-garde Expansion in Conversational AI Realm Unveiling Twilio’s Avant-garde Expansion in Conversational AI Realm

Twilio TWLO shares have shown brisk growth lately, outpacing both the Zacks Internet Software Industry and S&P 500 index. Investors’ exuberance stems from Twilio’s dominance in the customer engagement and communications sphere. In a strategic move, Twilio has joined forces with OpenAI, integrating OpenAI’s speech-to-speech capabilities into its platform through OpenAI’s Realtime API. This collaboration ...

Russ Cohen

Most Popular

Insightful Ultrahigh-Yield Dividend Stock Analysis The Unmissable Allure of Ultrahigh-Yield Dividend Stocks for Investors

Pfizer: A Financial Pillar with 5.81% yield Amidst the financial cacophony of Wall Street, Pfizer emerges as a beacon of stability for investors seeking solid ground. The pharmaceutical giant, despite navigating through the turbulent waters of a global pandemic, continues to deliver an impressive dividend yield of 5.81%. Pfizer’s strategic pivot towards groundbreaking medical solutions, ...

Russ Cohen

Most Popular

Comparing MercadoLibre and PDD Holdings A Comparative Analysis of MercadoLibre and PDD Holdings

Exploring the Business Variances Between Both Companies MercadoLibre navigates its marketplace across 18 Latin American countries, predominantly concentrating on Brazil, Mexico, and its native Argentina. Initially reliant on external vendors, it transitioned to hosting its marketplace and constructing an exclusive logistics network. The enterprise further cemented customer loyalty with its proprietary digital payment system, Mercado ...

Russ Cohen

Most Popular

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)

Investors Alert: Metagenomi Faces Class Action Lawsuit Deadline A Bumpy Road for Metagenomi Metagenomi, Inc., the once promising company that conducted its initial public offering (IPO) on February 13, 2024, now finds itself in a legal storm. Selling approximately 6.25 million shares at $15 per share sounded like music to investors’ ears. However, the melody ...

Russ Cohen

Most Popular

Top 3 Consumer Stocks Which Could Rescue Your Portfolio This Quarter

Unveiling Potential Gems: Consumer Stocks on the Verge of Recovery The Opportunity Amidst Oversold Stocks In the unpredictable dance of the stock market, where the rhythm can shift in an instant, oversold stocks often beckon as hidden gems waiting to be discovered. These gems, existing in the consumer discretionary sector, offer a glimmer of hope ...